EyePoint Pharmaceuticals
EYPT
#5921
Rank
NZ$2.09 B
Marketcap
NZ$24.94
Share price
3.29%
Change (1 day)
61.47%
Change (1 year)

Earnings for EyePoint Pharmaceuticals (EYPT)

Earnings in 2025 (TTM): -NZ$0.4 Billion

According to EyePoint Pharmaceuticals 's latest financial reports the company's current earnings are NZ$31.37 Million. a decrease over its 2024 earnings that were of -NZ$0.26 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for EyePoint Pharmaceuticals from 2003 to 2025

Annual earnings

Year Earnings Change
2025 -NZ$0.41 Billion63.24%
2024 -NZ$0.26 Billion104.29%
2023 -NZ$0.13 Billion-29.88%
2022 -NZ$0.18 Billion87.2%
2021 -NZ$93.54 Million38.58%
2020 -NZ$67.5 Million-24.56%
2019 -NZ$89.47 Million
2017 -NZ$40.81 Million22.59%
2016 -NZ$33.29 Million-8.02%
2015 -NZ$36.19 Million-296.09%
2014 NZ$18.45 M-174.02%
2013 -NZ$24.94 Million37.42%
2012 -NZ$18.15 Million-56.29%
2011 -NZ$41.51 Million-1062.38%
2010 NZ$4.31 M-250.43%
2009 -NZ$2.87 Million-89.5%
2008 -NZ$27.32 Million
2005 -NZ$16.85 Million56.99%
2004 -NZ$10.73 Million73.7%
2003 -NZ$6.18 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Nymox Pharmaceutical
NYMX
-NZ$3.82 Million-99.07% Bahamas
NRC Health
NRC
NZ$48.73 M-111.90%๐Ÿ‡บ๐Ÿ‡ธ USA